参考文献/References:
[1] 中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.
[2] TICINESI A,SINISCALCHI C,MESCHI T,et al.Gut microbiome and bone health:update on mechanisms,clinical correlations,and possible treatment strategies[J].Osteoporos Int,2025,36(2):167-191.
[3] 仝小林,何莉莎,赵林华.论“态靶因果”中医临床辨治方略[J].中医杂志,2015,56(17):1441-1444.
[4] 何莉莎,宋攀,赵林华,等.态靶辨证——中医从宏观走向精准的历史选择[J].辽宁中医杂志,2020,47(1):1-4.
[5] 黄振,李威,叶佰盛,等.由“虚瘀毒”理论探析细胞焦亡与骨质疏松的关联[J].中国骨质疏松杂志,2025,31(2):278-282.
[6] 王伟,万雷,柴爽,等.骨质疏松症的中医病因病机和分期治疗[J].中医正骨,2018,30(2):29-30.
[7] 史晓林,梁博程,李春雯.从“因虚致瘀”论原发性骨质疏松症病机[J].中国中西医结合杂志,2019,39(1):111-114.
[8] 蒋欣,杨小龙,张泽臣,等.由“虚瘀”理论探讨耆鹿逐痹胶囊防治肾虚血瘀型骨质疏松的作用[J].中国骨质疏松杂志,2024,30(6):880-883.
[9] 邹秀淇,郑承红,李云海,等.从“虚、痰、瘀、毒”分期论治糖尿病性骨质疏松症[J].中国骨质疏松杂志,2024,30(12):1787-1790.
[10] 刘馥溧,巴元明.巴元明从虚瘀毒论治肾性骨质疏松症的经验[J].中国中医骨伤科杂志,2024,32(1):85-87.
[11] HE Y,CHEN Y.The potential mechanism of the microbiota-gut-bone axis in osteoporosis:a review[J].Osteoporos Int,2022,33(12):2495-2506.
[12] 周志城,田瀚,庄旭锐,等.不同中医证型骨质疏松症患者肠道菌群的差异性分析[J].广州中医药大学学报,2024,41(9):2289-2295.
[13] ROPOTHSCHILD D,WEISSBROD O,BARKAN E,et al.Environment dominates over host genetics in shaping human gut microbiota[J].Nature,2018,555(7695):210-215.
[14] 董恩钊,冯学烽,李学圆,等.基于16SrRNA序列分析脾虚证骨质疏松症患者肠道菌群分布特点[J].广州中医药大学学报,2024,41(8):1947-1955.
[15] 丁维俊,高峰,杨杰,等.肾阳虚证患者肠道菌群失调状况的临床研究[J].新中医,2007,39(1):9-10.
[16] 张欢,周莹莹,于游,等.基于TMA/FMO3/TMAO信号通路探讨清脂通脉颗粒对膏脂转输障碍大鼠肠道微生态的调控机制[J].中华中医药学刊,2020,38(10):134-137.
[17] 陈浩,李甲,胡蕾,等.基于Sirt1-FXR通路探究京尼平苷酸对胆汁淤积大鼠胆汁酸肝肠循环的影响[J].中国中药杂志,2019,44(4):787-795.
[18] TONG L,FENG Q,LU Q,et al.Combined 1H NMR fecal metabolomics and 16S rRNA gene sequencing to reveal the protective effects of Gushudan on kidney-yang-deficiency-syndrome rats via gut-kidney axis[J].J Pharm Biomed Anal,2022,217:114843.
[19] FENG B,LU J,HAN Y,et al.The role of short-chain fatty acids in the regulation of osteoporosis:new perspectives from gut microbiota to bone health:a review[J].Medicine(Baltimore),2024,103(34):e39471.
[20] LIN Y H,LIAN W S,WU R W,et al.Trimethylamine-N-oxide accelerates osteoporosis by PERK activation of ATF5 unfolding[J].Cell Mol Life Sci,2024,82(1):13.
[21] CHEN Y,YANG C,DAI Q,et al.Gold-nanosphere mitigates osteoporosis through regulating TMAO metabolism in a gut microbiota-dependent manner[J].J Nanobiotechnology,2023,21(1):125.
[22] LYU Z,HU Y,GUO Y,et al.Modulation of bone remodeling by the gut microbiota:a new therapy for osteoporosis[J].Bone Res,2023,11(1):31.
[23] GAWALKO M,AGBAEDENG T A,SALJIC A,et al.Gut microbiota,dysbiosis and atrial fibrillation.Arrhythmogenic mechanisms and potential clinical implications[J].Cardiovasc Res,2022,118(11):2415-2427.
[24] MA Z,LIU Y,SHEN W,et al.Osteoporosis in postmeno-pausal women is associated with disturbances in gut microbiota and migration of peripheral immune cells[J].BMC Musculoskelet Disord,2024,25(1):791.
[25] GRÜNER N,ORTLEPP A L,MATTNER J.Pivotal role of intestinal microbiota and intraluminal metabolites for the maintenance of gut-bone physiology[J].Int J Mol Sci,2023,24(6):5161.
[26] GUO M,LIU H,YU Y,et al.Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure[J].Gut Microbes,2023,15(1):2190304.
[27] ALQRANEI M S,SENBANJO L T,ALJOHANI H,et al.Lipopolysaccharide-TLR-4 axis regulates osteoclastogenesis independent of RANKL/RANK signaling[J].BMC Immunol,2021,22(1):23.
[28] YU M,PAL S,PATERSON C W,et al.Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells[J].J Clin Invest,2021,131(4):e143137.
[29] PENG R,SONG C,GOU S,et al.Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor[J].Pharmacol Res,2024,202:107121.
[30] MCCABE L R,PARAMESWARAN N.Advances in probiotic regulation of bone and mineral metabolism[J].Calcif Tissue Int,2018,102(4):480-488.
[31] XIANG T,DENG Z,YANG C,et al.Bile acid metabolism regulatory network orchestrates bone homeostasis[J].Pharmacol Res,2023,196:106943.
[32] HANSDAH K,LUI J C.Emerging insights into the endocrine regulation of bone homeostasis by gut microbiome[J].J Endocr Soc,2024,8(8):bvae117.
[33] HU S,DING Q,ZHANG W,et al.Gut microbial beta-glucuronidase:a vital regulator in female estrogen metabolism[J].Gut Microbes,2023,15(1):2236749.
[34] BAKER J M,AL-NAKKASH L,HERBST-KRALOVETZ M M.Estrogen-gut microbiome axis:physiological and clinical implications[J].Maturitas,2017,103:45-53.
[35] 阮璐薇,张鹏横,胡柳,等.肠道菌群与绝经后骨质疏松症雌激素介导骨免疫失衡的相关性研究[J].中华中医药杂志,2020,35(2):820-823.
[36] 李伟举,陈晓聪,曾家莹,等.参骨颗粒通过肠道菌群改善骨质疏松的研究[J].中国骨质疏松杂志,2024,30(9):1341-1347.
[37] 周志城.基于肠道菌群论治补肾调肝方治疗骨质疏松的临床疗效[D].广州:广州中医药大学,2024.
[38] LI Q,WU X,NIU X,et al.Integrated metagenomic and metabolomic analyses of the effects of total flavonoids of Rhizoma Drynariae on reducing ovariectomized-induced osteoporosis by regulating gut microbiota and related metabolites[J].PLoS One,2025,20(2):e0317832.
[39] XIONG H H,LIN S Y,CHEN L L,et al.The interaction between flavonoids and intestinal microbes:a review[J].Foods(Basel,Switzerland),2023,12(2):320.
[40] LI J,HAOMING YOU,HU Y,et al.Effects of traditional Chinese medicine Zuo-Gui-Wan on gut microbiota in an osteoporotic mouse model[J].J Orthop Surg Res,2025,20(1):128.
[41] ZHAN W,DENG M,HUANG X,et al.Pueraria lobata-derived exosome-like nanovesicles alleviate osteoporosis by enhancing autophagy[J].J Control Release,2023,364:644-653.
[42] XUE H,LIANG B,WANG Y,et al.The regulatory effect of polysaccharides on the gut microbiota and their effect on human health:a review[J].Int J Biol Macromol,2024,270(Pt 2):132170.
[43] 韩京辰,廖建晖,吴官保,等.补肾活血汤对去势骨质疏松大鼠TLR4/MyD88/NF-κB信号通路及肠道菌群的影响[J].时珍国医国药,2024,35(5):1127-1131.
[44] LI W,LI T,TANG Z,et al.Taohong Siwu decoction promotes the process of fracture healing by activating the VEGF-FAK signal pathway and systemically regulating the gut micro-biota[J].J Appl Microbiol,2022,133(3):1363-1377.
[45] LI B,LIU M,WANG Y,et al.Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and re-pairing intestinal mucosal integrity[J].Biomed Pharmacother,2020,132:110923.
[46] 马靖,王凤云,张佳琪,等.基于细胞信号通路探讨葛根芩连汤治疗溃疡性结肠炎的研究进展[J].中国实验方剂学杂志,2021,27(17):186-192.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(07):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(07):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(07):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(07):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(07):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(07):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(07):16.
[11]陈斯亮,石瑛,汤辰明,等.基于16S核糖体RNA测序研究健脾方对绝经后骨质疏松症小鼠肠道菌群的影响[J].中医正骨,2023,35(06):11.
CHEN Siliang,SHI Ying,TANG Chenming,et al.A study of the effects of Jianpi Fang(健脾方)on intestinal flora of mice with postmenopausal osteoporosis based on 16S ribosomal RNA gene sequencing[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(07):11.